Teva Pharmaceutical Industries Ltd.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teva Pharmaceutical Industries Ltd.
The six months of additional exclusivity from US FDA’s CGT program appears to have kept some generic sponsors from the market, and didn’t even prompt others to enter quickly, but use of the competitive generic exclusivity program continues to grow.
Teva has opted against litigating with Pfizer over its controversial Xeljanz XR JAK inhibitor, settling patent infringement proceedings over a US patent scheduled to expire in 2034. Zydus Cadila recently bagged 180 days of exclusivity for a strength of its ANDA product.
HRA’s approval for pharmacy sales of a daily oral contraceptive the UK and its ongoing work on an NDA to propose making another progestin-only contraceptive ingredient available OTC in the US stand out as additions to Perrigo’s business with the most substantial revenue impacts.
Teva has dismissed its suit against Amicus Therapeutics after the latter agreed to provide requested quantities of its Fabry disease treatment Galafold. The quick resolution of the complaint illustrates the success of the CREATES Act in halting the drug supply dispute but leaves some unanswered questions.
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
- ABIC Marketing Limited
- Auspex Pharmaceuticals, Inc. (Imphar AG)
- Barr Pharmaceuticals
- Bentley Pharmaceuticals
- BioGeneriX AG
- BioAssets Development Corporation
- Cephalon, Inc. (Arana Therapeutics (Peptech and EvoGenix)
- Ception Therapeutics
- ChemGenex Pharmaceuticals Limited
- CIMA Labs
- Gemin X Pharmaceuticals
- CT Arzneimittel GmbH
- Gecko Health Innovations
- IVAX Corporation
- Labrys Biologics
- MicroDose Therapeutx Inc.
- Neose Technologies, Inc.
- NuPathe, Inc.
- PLIVA HRVATSKA d.o.o.
- ratiopharm Group
- Sicor Biotech
- Representaciones e Investigaciones Médicas, S.A. de C.V.
- Taiyo Pharmaceutical Industry Co. Ltd.
- Teva Branded Pharmaceutical Products, R&D Inc.
- Teva Women's Health, Inc.
- Actavis Generics
- Anda, Inc.
- Uteron Pharma S.P.R.L.
- Teva Takeda Yakuhin Ltd.
- Teva Takeda Pharma Ltd.
- Teva Neuroscience, Inc.
- Teva Pharmaceuticals USA, Inc.
- Zeneus Pharma